Oppenheimer analyst Jay Olson initiated coverage of Q32 Bio with an Outperform rating and $50 price target. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on QTTB: Q32 Bio names Lee Kalowski as CFO Q32 Bio initiated with an Overweight at Piper Sandler